-
公开(公告)号：US08759301B2
公开(公告)日：2014-06-24
申请号：US13024491
申请日：2011-02-10
CPC分类号： C07K14/4702 , A61K38/00 , C07K7/06 , C07K14/82
摘要： The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
摘要翻译： 本发明涉及用于癌症治疗的组合物和方法，包括但不限于癌症标志物的靶向抑制。 特别地，本发明涉及作为前列腺癌的临床靶标的复发性基因融合体。
-
公开(公告)号：US20100227910A1
公开(公告)日：2010-09-09
申请号：US12716653
申请日：2010-03-03
申请人： Arul M. Chinnaiyan , Jindan Yu , Ram Shankar Mani
发明人： Arul M. Chinnaiyan , Jindan Yu , Ram Shankar Mani
IPC分类号： A61K31/7105 , C12N5/071 , C07H21/02 , A61P35/00
CPC分类号： A61K31/7105 , C12N15/1135 , C12N2310/14
摘要： The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
摘要翻译： 本发明涉及用于癌症治疗的组合物和方法，包括但不限于癌症标志物的靶向抑制。 特别地，本发明涉及作为前列腺癌的临床靶标的复发性基因融合体。
-
公开(公告)号：US08143232B2
公开(公告)日：2012-03-27
申请号：US12716653
申请日：2010-03-03
申请人： Arul M. Chinnaiyan , Jindan Yu , Ram Shankar Mani
发明人： Arul M. Chinnaiyan , Jindan Yu , Ram Shankar Mani
CPC分类号： A61K31/7105 , C12N15/1135 , C12N2310/14
摘要： The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
摘要翻译： 本发明涉及用于癌症治疗的组合物和方法，包括但不限于癌症标志物的靶向抑制。 特别地，本发明涉及作为前列腺癌的临床靶标的复发性基因融合体。
-
公开(公告)号：US20110207675A1
公开(公告)日：2011-08-25
申请号：US13024491
申请日：2011-02-10
CPC分类号： C07K14/4702 , A61K38/00 , C07K7/06 , C07K14/82
摘要： The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.
摘要翻译： 本发明涉及用于癌症治疗的组合物和方法，包括但不限于癌症标志物的靶向抑制。 特别地，本发明涉及作为前列腺癌的临床靶标的复发性基因融合体。
-
-
-
搜索结果
4 条记录 (耗时 0.017 秒)
